Insulin sensitizers in 2023: lessons learned and new avenues for investigation.
Saved in:
| Title: | Insulin sensitizers in 2023: lessons learned and new avenues for investigation. |
|---|---|
| Authors: | Colca JR; CSO, Cirius Therapeutics Inc, Kalamazoo, MI, USA., Tanis SP; SP Tanis PharmaChem Consulting, Carlsbad, CA USA., Kletzien RF; MSDC, Grand Rapids, MI, USA., Finck BN; Department of Medicine, Center for Human Nutrition, Washington University in St Louis, Euclid Ave, MO, USA. |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2023 Jul-Dec; Vol. 32 (9), pp. 803-811. Date of Electronic Publication: 2023 Oct 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37755339 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Insulin sensitizers in 2023: lessons learned and new avenues for investigation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Colca+JR%22">Colca JR</searchLink>; CSO, Cirius Therapeutics Inc, Kalamazoo, MI, USA.<br /><searchLink fieldCode="AU" term="%22Tanis+SP%22">Tanis SP</searchLink>; SP Tanis PharmaChem Consulting, Carlsbad, CA USA.<br /><searchLink fieldCode="AU" term="%22Kletzien+RF%22">Kletzien RF</searchLink>; MSDC, Grand Rapids, MI, USA.<br /><searchLink fieldCode="AU" term="%22Finck+BN%22">Finck BN</searchLink>; Department of Medicine, Center for Human Nutrition, Washington University in St Louis, Euclid Ave, MO, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229434197%22">Expert opinion on investigational drugs</searchLink> [Expert Opin Investig Drugs] 2023 Jul-Dec; Vol. 32 (9), pp. 803-811. <i>Date of Electronic Publication: </i>2023 Oct 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9434197 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213543784%22">13543784 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Investig Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37755339 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/13543784.2023.2263369 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 803 Titles: – TitleFull: Insulin sensitizers in 2023: lessons learned and new avenues for investigation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Colca JR – PersonEntity: Name: NameFull: Tanis SP – PersonEntity: Name: NameFull: Kletzien RF – PersonEntity: Name: NameFull: Finck BN IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2023 Jul-Dec Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1744-7658 Numbering: – Type: volume Value: 32 – Type: issue Value: 9 Titles: – TitleFull: Expert opinion on investigational drugs Type: main |
| ResultId | 1 |